PATIENT-REPORTED OUTCOME IMPROVEMENT WITH TOFACITINIB IN THE ULCERATIVE COLITIS OCTAVE CLINICAL PROGRAMME

David P. Hudesman  1     Joana Torres  2     Leonardo Salese  3     John C. Woolcott  3     Rajiv Mundayat  4     Chinyu Su  4     Mahmoud Mosli  5     Jessica Allegretti  6    
1 Inflammatory Bowel Disease Center, New York, United States
2 Hospital Beatriz Ângelo, Loures, Portugal
3 Pfizer Inc, Collegeville, United States
4 Pfizer Inc, New York, United States
5 King Abdulaziz University Hospital, Jeddah, Saudi Arabia
6 Brigham and Women’s Hospital, Boston, United States

Topic
IBD, Immunology, Paediatrics

Session
Patient outcomes in IBD trials

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing